1. 1. Fleckenstein A (1970/71 a) Specific inhibitors and promoters of calcium action in the excitation-contraction coupling of heart muscle and their role in the production of prevention of myocardial lesions. In: Harris P, Opie L
2. 2. (eds) Calcium and the heart. Proceed. of the Meeting of the Europ. Section of the Internat. Study Group for Research in Cardiac Metabolism, London, Sept. 1970. Academic Press, London New York, pp 135-188.
3. Fleckenstein A (1977) Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle. Ann Rev Pharmacol Toxicol 17:149–166.
4. Fleckenstein A (1983) History of calcium antagonists. In: Schwartz A, Taira N (eds) Calcium channel-blocking drugs: A novel intervention for the treatment of cardiac disease. Monograph No. 95 of the American Heart Association, Circ. Research, Part II, vol 52, No. 2, pp 3-16.
5. Fleckenstein A (1983) Calcium antagonism in heart and smooth muscle — Experimental facts and therapeutic prospects. Wiley, New York Chichester Brisbane Toronto Singapore.